The effects of walking intervention in patients with chronic low back pain: A meta-analysis of randomized controlled trials

Sitthipornvorakul, Ekalak; Klinsophon, Thaniya; Sihawong, Rattaporn; Janwantanakul, Prawit

doi:10.1016/j.msksp.2017.12.003

Cited by 68 publications

(66 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Оценка КЖ отражает многофакторный подход, включающий физические, умственные и психические, со-циальные и функциональные аспекты состояния пациента. При ряде заболеваний нервной системы оценка КЖ активно включается в программы клинических исследований [2,[4][5][6]. ВОЗ рекомендует активно использовать показатель КЖ при исследовании новых лекарственных средств в неврологии [7], так как именно изменения КЖ во многом определяют выбор пациентами того или иного метода терапии [8].…”

Section: клиника и диагностикаunclassified

The improvement of quality of life of patients with multiple sclerosis over 15-year period

Boyko

Tatarinova

Popova

et al. 2018

Z. nevrol. psikhiatr. im. S.S. Korsakova

View full text Add to dashboard Cite

show abstract

Section: клиника и диагностикаunclassified

The improvement of quality of life of patients with multiple sclerosis over 15-year period

Boyko

Tatarinova

Popova

et al. 2018

Z. nevrol. psikhiatr. im. S.S. Korsakova

View full text Add to dashboard Cite

show abstract

“…education and physiotherapy) in patients with chronic LBP at both short-and intermediate-term follow up. 25 However, that review found the majority of the included studies failed to report intervention adherence which may have confounded the results. The authors therefore recommended further research to investigate the influence of adherence to walking interventions in improving the management of chronic LBP.…”

Section: Introductionmentioning

confidence: 99%

Accelerometer-based facilitated walking program in addition to usual care for the management of patients with low back pain at medium or high risk of chronicity: a randomised controlled trial protocol

et al. 2019

View full text Add to dashboard Cite

Background: The lifetime prevalence of low back pain (LBP) has been reported to be as high as 84% worldwide. Around 23% of the population has chronic non-specific LBP. Despite the potential health benefits of walking, few studies have investigated its effectiveness in people with non-specific LBP. The primary objective is to examine the efficacy of a Fitbit facilitated walking intervention in people with LBP with medium or high risk of chronicity in reducing disability and pain. The secondary objective is to investigate the efficacy of a Fitbit facilitated walking intervention in increasing physical activity levels in people with LBP.Methods: This prospective, randomised controlled trial will involve 68 participants. This study will recruit participants who are aged 18 years or over, have been diagnosed with non-specific LBP with medium or high risk of chronicity and classified as physically inactive. Participants will be randomised into two groups: usual physiotherapy care (n=34) and usual physiotherapy care plus Fitbit facilitated walking intervention program (n=34). The treatment duration will be 8 weeks. Primary outcomes for this study are disability and pain. Secondary outcomes include physical activity level and walking steps, depression, fear of movement and pain catastrophising. The outcomes will be assessed at baseline, post-intervention and 26 weeks post-randomisation follow-up.Conclusions: The results of this study will provide empirical evidence on the efficacy of a Fitbit facilitated walking intervention program, when added to usual care, in a clinical setting for improving disability and pain, and other clinical outcomes in people with LBP.Trial Registration: Australian New Zealand clinical trials registry (Number ACTRN12617001404314).

show abstract

“…Chronic LBP is the frequent chronic pain and notable health problem take on throughout the world [1][2][3]. Chronic LBP is also considered the most frequent source of disability, in addition to its increasing prevalence [4,5].…”

Section: Introductionmentioning

confidence: 99%

“…Approximately as many as 84% of individuals have at least an episode of LBP in their lifetime [5,6]. Among 24 -61% of individuals with acute LBP progress into chronic LBP [1,3,7] Chronic LBP is the main reason for disabling conditions, individual suffering, sick leave, and costly treatment [1,6,8]. It has a negative effect on the quality of life and also appends the socio-economic burden for individuals and communities [3].…”

Section: Introductionmentioning

confidence: 99%

“…Among 24 -61% of individuals with acute LBP progress into chronic LBP [1,3,7] Chronic LBP is the main reason for disabling conditions, individual suffering, sick leave, and costly treatment [1,6,8]. It has a negative effect on the quality of life and also appends the socio-economic burden for individuals and communities [3]. From the economic perspective, the impact of LBP is equivalent to other frequent, high-cost conditions, such as autoimmune, mental health, malignancy, and cardiovascular disease [9].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Tricyclic Antidepressants in Chronic Low Back Pain : A Review

Ilmanita

Hidayati

2020

J. Islamic Pharm.

View full text Add to dashboard Cite

Chronic low back pain (LBP) is the frequent chronic pain and notable health problem which is the main reason of disabling conditions, individual suffering, sick leave, and costly treatment. Unfortunately, available therapy especially oral medicines only beneficial in no more than 50% of patients. Tricyclic antidepressants (TCAs) are commonly used for neuropathic pain but the data for neuropathic LBP is limited. The purpose of this review is to evaluate the efficacy and adverse drug reaction of TCAs in chronic LBP. We searched scientific search engines including Scopus and PubMed and collected original articles including Randomized Clinical Trial (RCT), comparative, and observational study about Tricyclic Antidepressants treatment in chronic LBP from 1998 to 2019. In this review, 5 articles and 543 patients were evaluated. All recruited articles are randomized clinical trials. Among all five relevant articles, three of them evaluate amitriptyline treatment in chronic LBP while the rest articles evaluate imipramine and nortriptyline. Amitriptyline is the most well-studied TCA for chronic LBP. We found that both amitriptyline and nortriptyline can reduce pain severity significantly when the dose is increased gradually depending on patient tolerance. TCAs can also improve disability significantly. However, single-dose imipramine is not superior than placebo. We conclude that TCAs can be effective for treating chronic LBP when used routinely for several weeks and the dose should be increased gradually depending on patient tolerance although further studies are required to confirm the optimal dose for analgesia. The most prevalence Adverse Drug Reactions (ADRs) of TCA including dry mouth, somnolence, insomnia, sedation, and constipation.

show abstract

The effects of walking intervention in patients with chronic low back pain: A meta-analysis of randomized controlled trials

Cited by 68 publications

References 43 publications

The improvement of quality of life of patients with multiple sclerosis over 15-year period

The improvement of quality of life of patients with multiple sclerosis over 15-year period

Accelerometer-based facilitated walking program in addition to usual care for the management of patients with low back pain at medium or high risk of chronicity: a randomised controlled trial protocol

Tricyclic Antidepressants in Chronic Low Back Pain : A Review

Contact Info

Product

Resources

About